Thursday, 18 April 2024

[the_ad_group id="2845"]

Business News

Gemina Labs Strikes Major Licensing Deal – TipRanks Financial Blog

Pasithea Therapeutics Corp trading halted, news pending

[the_ad id="21475"]


Gemina Laboratories Ltd. (TSE:GLAB) has released an update.

Gemina Laboratories Ltd. has inked a landmark license agreement with a major global diagnostics company, marking a significant milestone in the commercialization of their intellectual property. This deal, which remains confidential, showcases the industry’s confidence in Gemina’s technology that has potential to save the lateral flow industry billions. The company is now pursuing additional licensing agreements to further leverage their cost-saving diagnostic technologies across various markets.

For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.

Click Here to Read the Full Original Article at TipRanks Financial Blog…


[the_ad id="21476"]